JIT(003029)2024-10-25 08:16Financial Performance - The company's revenue for Q3 2024 was ¥64,466,007.41, an increase of 4.74% compared to the same period last year, but a decrease of 13.02% year-to-date[2][7]. - The net profit attributable to shareholders was -¥40,102,801.14, representing a 21.46% increase from the previous year, while the year-to-date net profit was -¥71,290,576.24, a decrease of 14.32%[2][7]. - The basic earnings per share for Q3 2024 was -¥0.21, a 26.10% improvement year-over-year, with a year-to-date figure of -¥0.37, a decrease of 19.57%[2][7]. - Total operating revenue for the current period was ¥281,346,196.59, a decrease of 13.0% from ¥323,476,963.77 in the previous period[22]. - The company reported a net loss of -¥61,485,788.81 for the current period, an improvement from -¥72,217,829.66 in the previous period[22]. - Net profit attributable to shareholders of the parent company was -¥71,290,576.24, compared to -¥83,206,697.52 in the previous period, showing an improvement[23]. - Basic and diluted earnings per share were both -¥0.37, an improvement from -¥0.46 in the previous period[23]. Assets and Liabilities - Total assets as of September 30, 2024, were ¥1,680,259,583.73, down 10.21% from the end of the previous year[2][6]. - The company's total current assets decreased from CNY 1,183,639,772.99 at the beginning of the period to CNY 886,993,052.99 by the end of the period, representing a decline of approximately 25.1%[19]. - The company's total assets decreased from CNY 1,871,299,347.99 to CNY 1,680,259,583.73, a decline of about 10.2%[20]. - The company's total liabilities decreased significantly, with other payables down 96.62% to ¥7,290,425.58, due to the return of unvested equity incentive payments[6]. - Total liabilities decreased from CNY 638,545,404.64 to CNY 409,576,425.80, a reduction of approximately 35.8%[20]. - The total equity attributable to the parent company increased from CNY 1,186,759,932.36 to CNY 1,219,384,359.51, reflecting a growth of approximately 2.7%[21]. Cash Flow - The company's cash flow from operating activities year-to-date was -¥175,727,103.04, an increase of 19.36% compared to the previous year[2]. - The net cash flow from operating activities was -175,727,103.04 CNY, an improvement from -217,907,562.85 CNY in the previous year[25]. - Cash inflow from operating activities totaled ¥310,353,472.85, down 14.3% from ¥362,119,951.26 in the previous period[24]. - The company reported a significant decrease in cash and cash equivalents, down 55.06% to ¥313,494,779.74, primarily due to payments for long-term assets and share repurchases[6]. - The ending balance of cash and cash equivalents was 295,478,556.84 CNY, down from 443,877,435.07 CNY in the previous year[25]. - The company’s cash and cash equivalents decreased by 392,275,373.11 CNY during the quarter, compared to a decrease of 646,860,533.39 CNY in the same period last year[25]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 22,380[9]. - The largest shareholder, Yu Fengliang, holds 10.87% of shares, totaling 21,055,886 shares[9]. - The top ten shareholders include Jilin Province Bowei Industrial Co., Ltd. and Shanghai Yunxin Venture Capital Co., Ltd., holding 10.81% and 10.48% of shares, respectively[9]. - The company has repurchased a total of 5,219,800 shares, accounting for 2.70% of the total share capital, with a total repurchase amount of approximately RMB 72.72 million[12]. - The company has a total of 5,219,800 shares in its repurchase account, which have been excluded from the top ten shareholders list[11]. - The company has established a consistent action agreement among certain shareholders to maintain unified action in decision-making for 36 months[11]. - As of September 5, 2024, the major shareholder, Jilin Province Yingcai Investment Co., Ltd., reduced its shareholding to below 5% by selling 319,000 shares[15]. Expenses - Research and development expenses for Q3 2024 were ¥53,895,113.70, a decrease of 32.78% compared to the same period last year, reflecting a focus on cost reduction[7]. - Research and development expenses were ¥53,895,113.70, a decrease of 32.6% from ¥80,176,880.24 in the previous period[22]. - Sales expenses decreased to ¥119,403,232.48, down 5.3% from ¥126,704,718.85 in the previous period[22]. - The company experienced a significant increase in tax expenses, which rose to ¥3,741,958.27 from ¥1,424,897.77 in the previous period[22]. - The company paid 191,839,504.47 CNY to employees, a decrease from 227,133,090.50 CNY in the prior year[25]. Investment Activities - The net cash flow from investing activities was -¥118,166,681.83, a 69.65% improvement year-over-year, attributed to reduced cash payments for fixed assets and investments[8]. - Total cash outflow from investing activities was 144,268,831.51 CNY, compared to 389,498,808.40 CNY in the same period last year[25]. - Cash inflow from investment activities totaled 26,102,149.68 CNY, significantly lower than 99,235.00 CNY in the previous year[25]. - The company received 20,000,000.00 CNY from investment, a notable increase from 2,450,000.00 CNY last year[25].